-+ 0.00%
-+ 0.00%
-+ 0.00%

Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statement

PUBT·07/22/2026 23:11:13
Listen to the news
Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statement
  • Jasper Therapeutics COO Matthew E. Ros reported stock options for 103,204 voting common shares at USD 0.01.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-080523), on July 22, 2026, and is solely responsible for the information contained therein.